Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-03FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for metoclopramide from Teva Parenteral Medicines, Inc., updating the product's approval status as p…
-
FDA approval · 2010-05-27FDA Approved: FAMOTIDINE — Original Application (Navinta LLC)
FDA approves Navinta LLC's original application for famotidine. This approval permits a generic version of famotidine to enter the market.
-
CLINICAL_TRIALS trial_result · 2010-05-19Clinical Trial Update: Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD) [Phase 3]
A Phase 3 study evaluating pantoprazole for pediatric gastroesophageal reflux disease has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-05-19Clinical Trial Update: Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients [Phase 3]
Phase 3 trial assessed the efficacy and safety of esomeprazole once daily for gastroesophageal reflux disease in neonates. The study has com…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD [Phase 3]
This document reports the completion of a Phase 3 trial evaluating pantoprazole in neonates and preterm infants with gastroesophageal reflux…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-11Clinical Trial Update: Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US
This completed US study examines the partial response to proton pump inhibitors in gastroesophageal reflux disease and evaluates the societa…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD [Phase 3]
A Phase 3 trial evaluating pantoprazole in infants with presumed gastroesophageal reflux disease has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn [Phase 3]
Phase 3 study of a dexlansoprazole modified-release formulation for night-time gastroesophageal reflux symptoms completed; results were post…
-
FDA approval · 2010-04-30FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn [Phase 4]
Phase 4 clinical trial comparing rabeprazole and pantoprazole on stomach and esophageal acid exposure in patients with gastroesophageal refl…
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) [Phase 4]
An update on the safety study of rabeprazole in adults with gastroesophageal reflux disease conducted in Phase 4.
-
CLINICAL_TRIALS research · 2010-04-21Clinical Trial Update: Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients [Phase 2]
Phase 2 clinical trial evaluating ilaprazole for gastroesophageal reflux disease in Chinese patients; the study status is unknown.
-
FDA approval · 2010-04-15FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved Riley Consumer Care LLC's supplemental application for ZEGERID OTC, confirming its status as an over-the-counter omeprazole…
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals’ supplemental application for metoclopramide, updating the regulatory status of this generic drug.
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy [Phase 3]
This Phase 3, double-blind trial compared on-demand therapy with maintenance therapy for symptomatic gastroesophageal reflux disease. The st…
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: The Effect of Nexium on Transmucosal Esophageal Leak [Phase 1]
A Phase 1 clinical trial is evaluating whether Nexium (esomeprazole) affects transmucosal esophageal leak. The current status of the trial i…
-
FDA approval · 2010-03-04FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP. The approval update…
-
FDA approval · 2010-01-31FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine filed by Pharmaceutical Associates, Inc., updating the drug's labeling. This acti…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH [Phase 1]
Phase 1 trial comparing Vecam 40/300 and Vecam 20/300 with omeprazole 20 mg on gastric pH; the study has completed.
-
FDA approval · 2010-01-20FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application to update the labeling for Omeprazole and Sodium Bicarbonate (Oceanside Pharmaceuticals).
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of lansoprazole in patients with frequent nighttime heartburn. The study has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Medical and Surgical Treatment of Esophageal Reflux
Clinical trial update on medical and surgical treatment of gastroesophageal reflux; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique [NA]
A completed clinical trial evaluating whether cholecystectomy increases esophageal reflux, measured with impedance-pH monitoring, in patient…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) [Phase 3]
This Phase 3 trial evaluated pantoprazole for efficacy and safety in infants with symptomatic gastroesophageal reflux disease and has comple…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) [Phase 3]
Open-label Phase 3 safety study of an enteric-coated spheroid suspension in infants under 12 months with presumed gastroesophageal reflux di…